Market Research Logo

Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2018

Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Ophthalmic Lasers - Medical Devices Pipeline Assessment, 2018 provides an overview of Ophthalmic Lasers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Lasers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ophthalmic Lasers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Lasers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Lasers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Ophthalmic Lasers Overview
3 Products under Development
3.1 Ophthalmic Lasers - Pipeline Products by Stage of Development
3.2 Ophthalmic Lasers - Pipeline Products by Segment
3.3 Ophthalmic Lasers - Pipeline Products by Territory
3.4 Ophthalmic Lasers - Pipeline Products by Regulatory Path
3.5 Ophthalmic Lasers - Pipeline Products by Estimated Approval Date
3.6 Ophthalmic Lasers - Ongoing Clinical Trials
4 Ophthalmic Lasers - Pipeline Products under Development by Companies
4.1 Ophthalmic Lasers Companies - Pipeline Products by Stage of Development
4.2 Ophthalmic Lasers - Pipeline Products by Stage of Development
5 Ophthalmic Lasers Companies and Product Overview
5.1 3D-Micromac AG Company Overview
5.2 Alcon Laboratories Inc Company Overview
5.3 Bausch + Lomb Technolas Company Overview
5.4 Belkin Laser Ltd Company Overview
5.5 Biolase, Inc. Company Overview
5.6 Ellex Medical Lasers Limited Company Overview
5.7 IOPtima Ltd. Company Overview
5.8 Lensar Inc Company Overview
5.9 LumiThera, Inc. Company Overview
5.10 Michigan State University Company Overview
5.11 MRC Systems GmbH Company Overview
5.12 Nidek Co Ltd Company Overview
5.13 Princeton University Company Overview
5.14 Rowiak GmbH Company Overview
5.15 Spire Corp Company Overview
5.16 Stroma Medical Corp Company Overview
5.17 Studio Oculistico Gualdi Company Overview
5.18 University of Bern Company Overview
6 Ophthalmic Lasers- Recent Developments
6.1 Apr 25, 2018: Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
6.2 Apr 19, 2018: Novartis delivered a strong first quarter and acted to become a more focused medicines company
6.3 Apr 19, 2018: Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer
6.4 Apr 16, 2018: IRIDEX Announces Appointment of Maria Sainz and David Bruce to its Board of Directors
6.5 Apr 14, 2018: ZEISS presents diagnostic and surgical advancements at ASCRS
6.6 Apr 11, 2018: LENSAR Laser System Receives FDA Clearance to Perform Corneal Pockets and Flaps for Corneal Inlay Procedures
6.7 Apr 11, 2018: BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options
6.8 Apr 09, 2018: Cassini to present latest developments at the Ophthalmology Innovation Summit
6.9 Apr 05, 2018: Zecotek Provides Update for Zecotek Imaging China
6.10 Apr 04, 2018: BIOLASE Names Garrett Sato To Board Of Directors
6.11 Mar 23, 2018: 2RT to Feature at European Laser Innovation Forum 2018
6.12 Mar 22, 2018: LIGHTMED Appoints Dennis Dowell as Director of Sales and Marketing for North America
6.13 Mar 12, 2018: OD-OS Software Update for Navilas 577+ and Navilas 532 Benefits Long-Term Customers
6.14 Mar 12, 2018: Novartis announces changes to the Executive Committee to support strategic priorities
6.15 Mar 09, 2018: Oclaro's New 400G QSFP56-DD Delivers 400 Percent Increase in Bandwidth and Faceplate Density
6.16 Mar 08, 2018: IRIDEX Announces 2017 Fourth Quarter and Full Year Financial Results
6.17 Mar 07, 2018: Ellex at American Glaucoma Society Meeting, New York City
6.18 Mar 07, 2018: BIOLASE Secures $6 Million Revolving Line Of Credit
6.19 Feb 27, 2018: Ellex Medical Lasers: Release of Financial Results for Half-Year ended 31 December 2017
6.20 Feb 26, 2018: Lensar Names Richard L. Lindstrom As Board Director
6.21 Feb 09, 2018: Novartis layoffs to start in April at closing Broomfield plant
6.22 Feb 06, 2018: Spectralytics Opens Facility Dedicated to New Product Development
6.23 Feb 05, 2018: Ellex: Trading Update for Half-Year Ended 31 December 2017
6.24 Jan 29, 2018: Novartis India Appoints Jawed Zia As Vice Chairman And Managing Director
6.25 Jan 24, 2018: CAO Group Protects Its Diode Laser Patent Rights From Infringement By Biolase
6.26 Jan 09, 2018: IRIDEX Announces Infringement Lawsuit Against Quantel
6.27 Jan 08, 2018: IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year
6.28 Jan 04, 2018: LumiThera to Present at the Digital Medicine and MedTech Showcase Annual Conference on January 10, 2018
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Ophthalmic Lasers - Pipeline Products by Stage of Development
Table 2: Ophthalmic Lasers - Pipeline Products by Segment
Table 3: Ophthalmic Lasers - Pipeline Products by Territory
Table 4: Ophthalmic Lasers - Pipeline Products by Regulatory Path
Table 5: Ophthalmic Lasers - Pipeline Products by Estimated Approval Date
Table 6: Ophthalmic Lasers - Ongoing Clinical Trials
Table 7: Ophthalmic Lasers Companies - Pipeline Products by Stage of Development
Table 8: Ophthalmic Lasers - Pipeline Products by Stage of Development
Table 9: 3D-Micromac AG Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Excimer Laser System - Product Status
Table 11: Excimer Laser System - Product Description
Table 12: Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ALLEGRETTO EX-400 Laser - Product Status
Table 14: ALLEGRETTO EX-400 Laser - Product Description
Table 15: Bausch + Lomb Technolas Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Customlens - Product Status
Table 17: Customlens - Product Description
Table 18: TECHNOLAS TENEO 317 Excimer Laser - Product Status
Table 19: TECHNOLAS TENEO 317 Excimer Laser - Product Description
Table 20: Bausch + Lomb Technolas - Ongoing Clinical Trials Overview
Table 21: TECHNOLAS TENEO 317 Excimer Laser - A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK
Table 22: Belkin Laser Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 23: BELKIN Laser - Glaucoma - Product Status
Table 24: BELKIN Laser - Glaucoma - Product Description
Table 25: Belkin Laser Ltd - Ongoing Clinical Trials Overview
Table 26: BELKIN Laser - Glaucoma - Direct Selective Laser Trabeculoplasty (DSLT) in Open Angle Glaucoma (OAG): A Randomized Controlled Trial
Table 27: Biolase, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: YSGG Waterlase Laser - Presbyopia - Product Status
Table 29: YSGG Waterlase Laser - Presbyopia - Product Description
Table 30: Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Integre Pro Scan - Product Status
Table 32: Integre Pro Scan - Product Description
Table 33: IOPtima Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: IOPtiMate - Product Status
Table 35: IOPtiMate - Product Description
Table 36: Lensar Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: LensAR Laser System - Presbyopia - Product Status
Table 38: LensAR Laser System - Presbyopia - Product Description
Table 39: LENSAR Laser System with Streamline IV - Presbyopia - Product Status
Table 40: LENSAR Laser System with Streamline IV - Presbyopia - Product Description
Table 41: LumiThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 42: LT-300 LED - Product Status
Table 43: LT-300 LED - Product Description
Table 44: LumiThera, Inc. - Ongoing Clinical Trials Overview
Table 45: LT-300 LED - A Double-masked, Randomized, Sham-controlled, Parallel Group, Single-center Study to Assess the Safety and Efficacy of Photobiomodulation in Subjects with Dry Age-related Macular Degeneration
Table 46: Michigan State University Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Adaptive Laser System - Product Status
Table 48: Adaptive Laser System - Product Description
Table 49: MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 50: FLIM - Product Status
Table 51: FLIM - Product Description
Table 52: Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 53: NAVEX Quest - Product Status
Table 54: NAVEX Quest - Product Description
Table 55: Princeton University Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Presbyopia Correction Device - Product Status
Table 57: Presbyopia Correction Device - Product Description
Table 58: Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 59: LenSurgeon - Presbyopia Reversal - Product Status
Table 60: LenSurgeon - Presbyopia Reversal - Product Description
Table 61: Spire Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Fiber Laser Instrument - Eye Surgery - Product Status
Table 63: Fiber Laser Instrument - Eye Surgery - Product Description
Table 64: Stroma Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Stroma Ophthalmic Device - Eye Color - Product Status
Table 66: Stroma Ophthalmic Device - Eye Color - Product Description
Table 67: Studio Oculistico Gualdi Pipeline Products & Ongoing Clinical Trials Overview
Table 68: PEARL Inlay - Product Status
Table 69: PEARL Inlay - Product Description
Table 70: University of Bern Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Integrated Computer Assisted Retinal Laser Photocoagulation System - Product Status
Table 72: Integrated Computer Assisted Retinal Laser Photocoagulation System - Product Description
Table 73: Glossary
1.2 List of Figures
Figure 1: Ophthalmic Lasers - Pipeline Products by Stage of Development
Figure 2: Ophthalmic Lasers - Pipeline Products by Segment
Figure 3: Ophthalmic Lasers - Pipeline Products by Territory
Figure 4: Ophthalmic Lasers - Pipeline Products by Regulatory Path
Figure 5: Ophthalmic Lasers - Pipeline Products by Estimated Approval Date
Figure 6: Ophthalmic Lasers - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report